Mucormycosis is an angioinvasive fungal infection, due to fungi of the order Mucorales. Its
incidence cannot be measured exactly, since there are few population-based studies, but …

In its wake, the COVID‐19 pandemic has ushered in a surge in the number of cases of
mucormycosis. Most cases are temporally linked to COVID‐19; hence, the entity is described …

Abstract During September–December 2020, we conducted a multicenter retrospective
study across India to evaluate epidemiology and outcomes among cases of coronavirus …

Purpose: COVID-19-associated rhino-orbital-cerebral mucormycosis (ROCM) has reached
epidemic proportion during India's second wave of COVID-19 pandemic, with several risk …

The pandemic of coronavirus disease 2019 (COVID-19) still remains on an upsurge trend.
The second wave of this disease has led to panic in many countries, including India and …

Reports are increasing on the emergence of COVID‐19–associated mucormycosis (CAM)
globally, driven particularly by low‐and middle‐income countries. The recent unprecedented …

Mucormycosis is an angio-invasive fungal infection, associated with high morbidity and
mortality. A change in the epidemiology of mucormycosis has been observed in recent years …

Background The epidemiology of mucormycosis in the era of modern diagnostics is
relatively under-explored. Objectives To examine the contemporary epidemiology, clinical …

Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and …

The European Conference on Infections in Leukemia (ECIL) provides recommendations for
diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various …